Devices & Diagnostics

Medtronic: top regulatory affairs officer retiring

Medtronic confirms that Susan Alpert will be retiring from her post as the medical device giant’s top regulatory official at the end of April. Medtronic Inc.’s (NYSE:MDT) chief regulatory affairs officer Susan Alpert will join her boss, William Hawkins, on Retirement Row this year, according to company officials. Alpert, who has held the senior vice […]

Medtronic confirms that Susan Alpert will be retiring from her post as the medical device giant’s top regulatory official at the end of April.

Medtronic Inc.’s (NYSE:MDT) chief regulatory affairs officer Susan Alpert will join her boss, William Hawkins, on Retirement Row this year, according to company officials.

Alpert, who has held the senior vice president and chief regulatory officer positions at Medtronic since 2005, had a similar role at C.R. Bard (NYSE:BCR) before joining MDT and is also a former director of the FDA’s Office of Device Evaluation.

Spokesman Brian Henry confirmed Alpert‘s retirement to MassDevice in an email, writing that she will step down as of the end of Medtronic’s fiscal year later this month.

Read more Medtronic coverage from MassDevice.com

“It’s been an absolute pleasure working with her. Her knowledge of the industry, of regulatory agencies and of the importance of collaboration between the two for the benefit of patients, is unsurpassed,” Henry told us. “Her guidance and counsel have been extremely valuable and we’re pleased that she plans to continue to offer both even in her retirement.”

Henry said the Fridley, Minn.-based company has already tapped Alpert’s replacement, regulatory affairs vice president Patricia Shrader. Shrader is the former regulatory SVP at Becton, Dickinson & Co. (NYSE:BEC).

The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.